Minimally Invasive Treatments of Dupuytren Disease: An Overview

Ji Hyun Yeo, Jin Young Kim

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations

Abstract

Dupuytren disease (DD) is a fibroproliferative disorder that originates at the palmar fascia and results in flexion contracture of the digits. The gold standard treatment for DD has been surgery. Surgical treatment of DD can be done with various methods, from percutaneous needle fasciotomy to dermatofasciectomy. The most commonly used surgical treatment is limited fasciectomy (LF). The potential complications of limited fasciectomy include long recovery time, scarring, neurovascular injury, and tendon injury. Minimally invasive treatment for DD, which is simple and allows for rapid return of function, has gained popularity amongst both patients and surgeons. Currently, minimally invasive treatments for DD include percutaneous needle fasciotomy (PNF) and collagenase clostridium histolyticum (CCH). In this review, we provide an overview of the minimally invasive treatments for Dupuytren disease and summarize the current evidence regarding these minimally invasive treatments.

Original languageEnglish
Pages (from-to)131-141
Number of pages11
JournalJournal of Hand Surgery Asian-Pacific Volume
Volume26
Issue number2
DOIs
StatePublished - 1 Jun 2021

Keywords

  • Clostridium histolyticum
  • Collagenase
  • Dupuytren contracture
  • Fasciotomy
  • Minimally invasive treatment

Fingerprint

Dive into the research topics of 'Minimally Invasive Treatments of Dupuytren Disease: An Overview'. Together they form a unique fingerprint.

Cite this